PET > PET tumor imaging > Head and Neck Tumors

J Nucl Med 1995 Feb;36(2):211-6

Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.

Braams JW, Pruim J, Freling NJ, Nikkels PG, Roodenburg JL, Boering G, Vaalburg W, Vermey A.

The uptake of 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in neck lymph nodes of twelve patients with a squamous-cell carcinoma of the oral cavity was studied with PET in order to detect and locate lymphogenic metastases. METHODS: The results of FDG-PET imaging were compared with clinical, MRI and histopathologic findings. Standardized uptake values (SUV) were also calculated. RESULTS: A sensitivity of 91% and a specificity of 88% were calculated for FDG-PET. In contrast, a sensitivity of 36% and a specificity of 94% were calculated for MRI. Calculated SUVs for reactive lymph nodes, metastatic lymph nodes and the primary tumor were undifferentiated. CONCLUSION: Using FDG-PET, lymph node metastases of squamous-cell carcinomas of the oral cavity can be visualized with a high sensitivity and specificity. FDG-PET can be an improvement in the evaluation of the neck.

Page 1 of 30
Next Page